Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- ROX +20.5%, LAKE +9.7%, NAKD +4.8%, BOBE +3.5%, JBL +2%
Other news:
- IDXG +22.4% (still checking; notable mover that was down 20%+ this week)
- HTGM +22.2% (HTGM entered into a statement of work with QIAGEN Manchester for Master Assay Development, Commercialization and Manufacturing Agreement)
- SKLN +19.6% (has notified the Dutch Competent Authority that the Company's STREAMWAY System meets all requirements and can now be affixed with the CE mark)
- ADMP +10.7% (Adamis Pharma rebounding in after hours trade ahead of tomorrow's PDUFA date for Epinephrine Pre-filled Syringe)
- CTIC +8.1% (receives a $10 mln milestone payment from Teva Pharmaceutical (TEVA) related to the achievement of sales milestones for TRISENOX)
- HAIN +2.5% (confirms will conduct a call to discuss its financial results on Thursday, June 22, 2017 at 8am ET and expects to file Annual Report and Quarterly Reports on that day)
- PSDV +2.3% (modestly rebounding from this week's decline; Pres/CEO disclosed the purchase of 56,700 shares at avg price of $1.763/share)
- AVXS +1.9% (announces alignment w/ the FDA on its Good Manufacturing Practice commercial manufacturing process for AVXS-101 following the receipt of minutes from the Type B CMC meeting; expects to have the data ready to submit to the FDA in the August timeframe )
Analyst comments:
- YTRA +6.5% (initiated with a Buy at Deutsche Bank)
- LQ +1.2% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- AAAP +0.7% (initiated with a Overweight at JP Morgan